Karmanos Cancer Institute Adopts UroNav Technology to Diagnose Prostate Cancer

Karmanos Cancer Institute Adopts UroNav Technology to Diagnose Prostate Cancer
Urologists at Detroit's Barbara Ann Karmanos Cancer Institute have switched to a more sophisticated technology for diagnosing prostate cancer: the UroNav Fusion Biopsy System. UroNav fuses 3D magnetic resonance imaging (MRI) pictures of the prostate with live ultrasound images to guide the biopsy procedure. The machine fuses images so they move and change in real time as urologists perform biopsies. "An MRI is better at seeing tumors in the prostate," Michael Cher, MD, chair of urology at Karmanos, said in a
Subscribe or to access all post and page content.